Poster Abstract Session:
113. Clinical Practice Issues
Friday, October 4, 2013: 12:30 PM-2:00 PM
Room: The Moscone Center: Poster Hall C

Tracks: Adult ID


Optimizing Health Information Technology for Clinical Research: Developing an Infectious Disease Research Data Repository (a Multi-Site Electronic Data Infectious Diseases Consortium [MEDIC] study)
Lois Lamerato, PhD ; Laura A. Puzniak, PhD, MPH ; Steven Lawrence, MD, MSc ; Anthony D. Harris, MD, MPH ; Andrew Masica, MD, MSCI ; Marcus Zervos, MD
  • Lamerato_poster.pdf (347.5 kB)

  • 826
    First Year Experience of a Hospital-based Out-patient Antimicrobial Parenteral Therapy Unit
    Joanna Kopacz, MD ; Javeria Shakil, MD ; Nauman Piracha, MD ; Deborah Figueroa, PharmD ; Caroline Keane, RN ; Ruth Hopkins, RN ; Alexander Melchert ; Michaelle Williams, RN ; Marcia Levine, RN ; Stephen Rimar, MD ; Sorana Segal-Maurer, MD

    Utilization of an Outpatient Parenteral Antibiotic Treatment Center (OPATC) to Decrease Preventable Hospitalizations and Readmissions
    Lindsey Reese, MD, MSCR ; Loren Jacobus, RN, CRNI ; John Lock, PharmD ; Markian Bochan, MD, PhD, FIDSA
  • 827_IDWPOSTER.pdf (396.3 kB)

  • 828
    Outcomes in an Outpatient Parenteral Antimicrobial Therapy Program at a Tertiary Care Hospital
    Nabin Shrestha, MD, MPH, FIDSA ; Jugnu Shrestha ; Angela Everett ; Don Carroll ; Steven Gordon, MD, FIDSA, FSHEA ; Susan J. Rehm, MD
  • Shrestha 75505 final.pdf (114.9 kB)

  • 830
    Low correlation between self-report and medical record documentation of urinary tract infection (UTI) symptoms
    Jose Echaiz, MD ; Candice Cass ; Jeffrey P. Henderson, MD PhD ; Hilary M. Babcock, MD, MPH ; Jonas Marschall, MD

    Elevated Plasma Fluoride Concentrations in Patients Receiving Long-Term Voriconazole
    Timothy J. Jancel, PharmD ; Kenneth Olivier, MD, MPH ; Alexandra F. Freeman, MD ; Christa Zerbe, MD, MS ; Steven Holland, MD

    Nafcillin-Induced Hypokalemia
    Nasira Roidad, MD ; Rashida Khakoo, MD, MACP ; John Guilfoose, MD

    Outpatient parenteral antimicrobial therapy (OPAT) practice variation and safety: results of an Emerging Infections Network survey
    Michael A. Lane, MD, MSc ; Jonas Marschall, MD ; Susan Beekmann, MPH ; Philip M. Polgreen, MD ; Ritu Banerjee, MD, PhD ; Adam L. Hersh, MD, PhD ; Hilary M. Babcock, MD, MPH

    Clinical Success in Outpatient Treatment of Complicated Urinary Tract Infections (UTI) with Ertapenem
    Lucinda J. Van Anglen, PharmD ; Philip Brachman, MD, FACP, FIDSA ; Fernando S. Alvarado, MD, MPH & TM ; Jennifer L. Christensen, PharmD, BCPS

    Outpatient Parenteral Antimicrobial Therapy (OPAT) for Treatment of Complicated Intra-Abdominal Infections
    Fernando S. Alvarado, MD, MPH & TM ; Ramesh V. Nathan, MD ; H. Barry Baker, MD, FACP ; Richard L. Levine, MD ; Andrew H. Krinsky, MD ; Richard C. Prokesch, MD, FACP, FIDSA ; Philip Brachman, MD, FACP, FIDSA ; Lucinda J. Van Anglen, PharmD

    CME Credits:

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.